Tag: FDAInspection

• 

  Lupin Receives USFDA Establishment Inspection Report for New Jersey Facility: A Positive Milestone Amidst Strong Financial Performance

  Lupin has successfully received the Establishment Inspection Report (EIR) from the USFDA for its Somerset facility in New Jersey. This milestone highlights the company’s dedication to maintaining high-quality manufacturing standards and strengthens its position in global pharmaceutical markets.